CTI BioPharma
3101 Western Avenue,
Seattle, 98121, WA,
United States
Seattle, 98121, WA,
United States
1 858-465-6511
Life Sciences
CTI BioPharma Technographics
CTI BioPharma Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by CTI BioPharma and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 121 CTI BioPharma employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that CTI BioPharma has purchased the following applications: Oracle Discoverer for Analytics and BI in 2009, Microsoft 365 for Collaboration in 2016, DocuSign eSignature for Digital Signing in 2021 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems CTI BioPharma is running and its propensity to invest more and deepen its relationship with Oracle , Microsoft , CodeTwo or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing CTI BioPharma revenues, which have grown to $15.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for CTI BioPharma intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
CTI BioPharma Tech Stack and Enterprise Applications
CTI BioPharma Analytics and BI
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle Discoverer | Analytics and BI | Analytics and BI | n/a | 2009 | 2009 |
In 2009, CTI BioPharma implemented Oracle Discoverer 10g to support Analytics and BI across its Oracle Applications environment. The deployment was built on Oracle Apps 12 with DB 10g, and it leveraged BIS Views as the primary reporting semantic layer alongside Oracle Discoverer 10g workbooks and ad hoc query capabilities.
Configuration focused on category aligned reporting workflows, using Oracle Discoverer for ad hoc analysis, scheduled reports, and workbook distribution. The implementation incorporated MOAC to enable cross organization access and integrated subledger detail from the XLA subledger, while TOAD, SQL and PL SQL were used for custom data extracts and report tuning.
Operational governance emphasized metadata and security control, using BIS Views to standardize subject areas and VPD to enforce row level security and role based access. Development and maintenance processes were centered on SQL and PL SQL procedures to refresh BIS Views and maintain Discoverer objects, aligning Analytics and BI output with the Oracle Applications financial and subledger data model.
|
CTI BioPharma Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2016 | 2016 |
In 2016, CTI BioPharma implemented Microsoft 365 to support Collaboration across the organization. The company lists Microsoft 365 on its public website, indicating a cloud-hosted Microsoft 365 tenancy provisioned for corporate collaboration and externally visible content delivery.
The Microsoft 365 implementation centers on core Collaboration capabilities, including Exchange Online for enterprise email, SharePoint Online for intranet and document management, OneDrive for Business for user file storage, and Microsoft Teams for real-time communication and meetings. Identity and access management is aligned with Microsoft 365 patterns, using Azure Active Directory and platform security features such as conditional access, multi-factor authentication, and information protection labeling to manage authentication and data classification.
Operational coverage targets CTI BioPharma’s internal business functions across corporate and scientific teams within its United States operations and workforce of approximately 121 employees. Governance emphasis follows typical Microsoft 365 deployments, with centralized user provisioning, role-based access controls, retention and compliance policy configuration, and controls for external sharing and authentication that support the application’s public-facing presence on the corporate website.
|
|
|
|
|
Collaboration | Collaboration |
|
2021 | 2021 |
|
CTI BioPharma Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, CTI BioPharma deployed DocuSign eSignature on its public website to enable electronic signature capture for external document workflows. DocuSign eSignature is used as the companys Digital Signing solution to support web-based signing experiences, document preparation, template-driven routing, recipient authentication, and audit trail capture for in-browser signature completion.
The implementation embeds DocuSign eSignature functionality into website pages to present signing sessions directly within the browser, leveraging the applications native template and envelope management capabilities to standardize document routing and recipient sequencing. Administrative controls and audit logs within DocuSign eSignature are used to enforce signature governance and provide traceability for executed documents, and operational scope centers on customer-facing and external stakeholder document execution workflows delivered through the corporate website.
|
|
|
|
|
Web Content Management | Content Management |
|
2021 | 2021 |
|
CTI BioPharma CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2020 | 2020 |
|
|
|
|
|
Sales Automation, CRM, Sales Engagement | CRM |
|
2021 | 2021 |
|
CTI BioPharma IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2016 | 2016 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
CTI BioPharma CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
|
|
|
|
Secure Email Gateways (SEGs) | CyberSecurity |
|
2016 | 2016 |
|
IT Decision Makers and Key Stakeholders at CTI BioPharma
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by CTI BioPharma Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from CTI BioPharma IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the CTI BioPharma digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD CTI BioPharma Technographics
CTI BioPharma is a Life Sciences organization based in United States,
with around 121 employees and annual revenues of $15.0 million.
CTI BioPharma operates a diverse technology stack with applications such as
Oracle Discoverer, Microsoft 365 and DocuSign eSignature,
covering areas like Analytics and BI, Collaboration and Digital Signing.
CTI BioPharma has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Oracle, Microsoft and DocuSign.
CTI BioPharma recently adopted applications including
CodeTwo Email Signatures in 2021, DocuSign eSignature in 2021 and CIVIC Ffora in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of CTI BioPharma’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates CTI BioPharma’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete CTI BioPharma technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.